Hepatic and other medical disorders of alcoholism: From pathogenesis to treatment

Journal of Studies on Alcohol

Volumn 59, Issue 1, 1997, Pages 9-25

  Lieber, Charles S ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ALCOHOL DEHYDROGENASE;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLISM; CARDIOVASCULAR DISEASE; DISEASE SEVERITY; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; LIVER METABOLISM; PATHOGENESIS; REVIEW;

EID: 6844237683     PISSN: 0096882X     EISSN: None     Source Type: Journal    
DOI: 10.15288/jsa.1998.59.9     Document Type: Review

References (195)

1. ABEL, E.L. AND SOKOL, R.J. A revised conservative estimate of the incidence of FAS and its economic impact. Alcsm Clin. Exp. Res. 15: 514-524, 1991.
2. ADAMS, W.L., YUAN, Z., BARBORIAK, J.J. AND RIMM, A.A. Alcohol-related hospitalizations of elderly people: Prevalence and geographic variation in the United States. JAMA 270: 1222-1225, 1993.
3. AHMED, S., LEO, M.A. AND LIEBER, C.S. Interactions between alcohol and beta-carotene in patients with alcoholic liver disease. Amer. J. Clin. Nutr. 60: 430-436, 1994.
4. ALBANES, D., HEINONEN, O.P., TAYLOR, P.R., VIRTAMO, J., EDWARDS, B.K., RAUTALAHTI, M., HARTMAN, A.M., PALMGREN, J., FREEDMAN, L.S., HAAPAKOSKI, J., BARRETT, M.J., PIETINEN, P., MALILA, N., TALA, E., LIIPO, K., SALOMAA, E.-R., TANGREA, J.A., TEPPO, L., ASKIN, F.B., TASKINEN, E., EROZAN, Y., GREENWALD, P. AND HUTTUNEN, J.K. α-tocopherol and β-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: Effects of base-line characteristics and study compliance. J. Natl. Cancer Inst. 88: 1560-1571, 1996.
5. ALPHA-TOCOPHEROL, BETA-CAROTENE CANCER PREVENTION STUDY GROUP. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New Engl. J. Med. 330: 1029-1035, 1994.
6. ARAI, M., GORDON, E.R. AND LIEBER, C.S. Decreased cytochrome oxidase activity in hepatic mitochondria after chronic ethanol consumption and the possible role of decreased cytochrome aa3 content and changes in phospholipids. Biochim. Biophys. Acta 797: 320-327, 1984a.
7. ARAI, M., LEO, M.A., NAKANO, M., GORDON, E.R. AND LIEBER, C.S. Biochemical and morphological alterations of baboon hepatic mitochondria after chronic ethanol consumption. Hepatology 4: 165-174, 1984b.
8. BARAONA, E., LEO, M.A., BOROWSKY, S.A. AND LIEBER, C.S. Pathogenesis of alcohol-induced accumulation of protein in the liver. J. Clin. Invest. 60: 546-554, 1977.
9. BARAONA, E. AND LIEBER, C.S. Effects of chronic ethanol feeding on serum lipoprotein metabolism in the rat. J. Clin. Invest. 49: 769-778, 1970.
10. BARAONA, E., YOKOYAMA, A., ISHII, H., HERNÁNDEZ-MUÑOZ, R., TAKAGI, T., TSUCHIYA, M. AND LIEBER, C.S. Lack of alcohol dehydrogenase isoenzyme activities in the stomach of Japanese subjects. Life Sci. 49: 1929-1934, 1991.
11. BASHIR, R., DAY, C.P., JAMES, O.F.W., OGILVIE, D.J., SYKES, B. AND BASSENDINE, M.F. No evidence for involvement of type I collagen structural genes in "genetic predisposition" to alcoholic cirrhosis. J. Hepatol. 16: 316-319, 1992.
12. BESKID, M., BIALEK, J., DZIENISZEWSKI, J., SADOWSKI, J. AND TLALKA, J. Effect of combined phenylbutazone and ethanol administration on rat liver. Exp. Pathol. 18: 487-491, 1980.
13. BLACK, M. Acetaminophen hepatotoxicity. Ann. Rev. Med. 35: 577-593, 1984.
14. 2 receptor gene in alcoholism. JAMA 263: 2055-2060, 1990.
15. BODEN, G., CHEN, X., DESANTIS, R., WHITE, J. AND MOZZOLI, M. Effects of ethanol on carbohydrate metabolism in the elderly. Diabetes 42: 28-34, 1993.
16. BOFFETTA, P. AND GARFINKEL, L. Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study. Epidemiology 1: 342-348, 1990.
17. 2 receptor gene and alcoholism. JAMA 264: 3156-3160, 1990.
18. BOROWSKY, S.A. AND LIEBER, C.S. Interaction of methadone and ethanol metabolism. J. Pharmacol. Exp. Ther. 207: 123-129, 1978.
19. 2-receptor antagonists on gastric alcohol dehydrogenase activity. Dig. Dis. Sci. 36: 1673-1679, 1991.
20. CABALLERIA, J., BARAONA, E., RODAMILANS, M. AND LIEBER, C.S. Effects of cimetidine on gastric alcohol dehydrogenase activity and blood ethanol levels. Gastroenterology 96: 388-392, 1989.
21. CARULLI, N., MANENTI, F., GALLO, M. AND SALVIOLI, G.F. Alcohol-drugs interaction in man: Alcohol and tolbutamide. Eur. J. Clin. Invest. 1: 421-424, 1971.
22. CASINI, A., CUNNINGHAM, M., ROJKIND, M. AND LIEBER, C.S. Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology 13: 758-765, 1991.
23. CHEDID, A., MENDENHALL, C.L., GARTSIDE, P., FRENCH, S.W., CHEN, T., RABIN, L. AND THE VA COOPERATIVE STUDY GROUP. Prognostic factors in alcoholic liver disease. Amer. J.Gastroenterol. 86: 210-216, 1991.
24. COLDITZ, G.A. A prospective assessment of moderate alcohol intake and major chronic diseases. Ann. Epidemiol. 1: 167-177, 1990.
25. DAY, C.P., BASHIR, R., JAMES, O.F.W., BASSENDINE, M.F., CRABB, D.W., THOMASSON, H.R., LI, T.-K. AND EDENBERG, H.J. Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damage. Hepatology 14: 798-801, 1991.
26. DEVENYI, P., ROBINSON, G.M., KEPEN, B.M. AND RONCARI, D.A.K. High-density lipoprotein cholesterol in male alcoholics with and without severe liver disease. Amer. J. Med. 71: 589-594, 1981.
27. DICKER, E. AND CEDERBAUM, A.I. Increased oxygen radical-dependent inactivation of metabolic enzymes by liver microsomes after chronic ethanol consumption. FASEB J. 2: 2901-2906, 1988.
28. DIETARY GUIDELINES FOR AMERICANS. Home and Garden Bulletin, No. 232, 4th Edition, Washington, D.C.: Human Nutrition Information Service, Department of Agriculture, 1995.
29. 2-receptor antagonists. JAMA 267: 83-86, 1992.
30. DIPADOVA, C., WORNER, T.M., JULKUNEN, R.J.K. AND LIEBER, C.S. Effects of fasting and chronic alcohol consumption on the first-pass metabolism of ethanol. Gastroenterology 92: 1169-1173, 1987.
31. 6-methylguanine transferase. Carcinogenesis 9: 761-766, 1988.
32. FALLER, J. AND FOX, I.H. Evidence for increased urate production by activation of adenine nucleotide turnover. New Engl. J. Med. 307: 1598-1602, 1982.
33. FEELY, J. AND WOOD, A.J.J. Effects of cimetidine on the elimination and actions of ethanol. JAMA 247: 2819-2821, 1982.
34. FORMAN, M.R., BEECHER, G.R., LANZA, E., REICHMAN, M.E., GRAUBARD, B.I., CAMPBELL, W.S., MARR, T., YONG, L.C., JUDD, J.T. AND TAYLOR, P.R. Effect of alcohol consumption on plasma carotenoid concentrations in premenopausal women: A controlled dietary study. Amer. J. Clin. Nutr. 62: 131-135, 1995.
35. FRASER, A.G., HUDSON, M., SAWYER, A.M., OSALKI, S.B. AND POUNDER, R.E. Short report: The effect of ranitidine on post-prandial absorption of a low dose of alcohol. Aliment. Pharmacol. Ther. 6: 267-271, 1992.
36. FREZZA, M., DIPADOVA, C., POZZATO, G., TERPIN, M., BARAONA, E. AND LIEBER, C.S. High blood alcohol levels in women: The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. New Engl. J. Med 322: 95-99, 1990.
37. FRIEDMAN, S.L. The cellular basis of hepatic fibrosis: Mechanisms and treatment strategies. New Engl. J. Med. 328: 1828-1835, 1993.
38. FUKUNAGA, T., SILLANAUKEE, P. AND ERIKSSON, C.J.P. Occurrence of blood acetaldehyde in women during ethanol intoxication: Preliminary findings. Alcsm Clin. Exp. Res. 17: 1198-1200, 1993.
39. GARRO, A.J., ESPINA, N., MCBETH, D., WANG, S.-L. AND WU-WANG, C.Y. Effects of alcohol consumption on DNA methylation reactions and gene expression: Implications for increased cancer risk. Eur. J. Cancer Prev. 1 (Suppl. 3): 19-23, 1992.
40. GARRO, A.J. AND LIEBER, C.S. Alcohol and cancer. Ann. Rev. Pharmacol. Toxicol. 30: 219-249, 1990.
41. 2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. JAMA 271: 204-208, 1994.
42. GOMBERG, E.S.L. Women and alcohol: Use and abuse. J. Nerv. Ment. Dis. 181: 211-219, 1993.
43. GRASSI, G.G. AND GRASSI, C. Ethanol-antibiotic interactions at hepatic level. Int. J. Clin. Pharmacol. 11: 216-225, 1975.
44. GRONBAEK, M., HENRIKSEN, J.H. AND BECKER, U. Carbohydrate-deficient transferrin - A valid marker of alcoholism in population studies? Results from the Copenhagen City Heart Study. Alcsm. Clin. Exp. Res. 19: 457-461, 1995.
45. GUIVERNAU, M., BARAONA, E. AND LIEBER, C.S. Acute and chronic effects of ethanol and its metabolites on vascular production of prostacyclin in rats. J. Pharmacol. Exp. Ther. 240: 59-64, 1987.
46. GUPTA, A.M., BARAONA, E. AND LIEBER, C.S. Significant increase of blood alcohol by cimetidine after repetitive drinking of small alcohol doses. Alcsm Clin. Exp. Res. 19: 1083-1087, 1995.
47. 2-receptor antagonists. Alcsm. Clin. Exp. Res. 15: 1084-1085, 1991.
48. HABER, P.S., GENTRY, T., MAK, K.M., MIRMIRAN-YAZDY, S.A.A., GREENSTEIN, R.J. AND LIEBER, C.S. Metabolism of alcohol by human gastric cells: Relation to first-pass metabolism. Gastroenterology 111: 863-870, 1996.
49. HARTUNG, G.H., FOREYT, J.P., MITCHELL, R.E., MITCHELL, J.G., REEVES, R.S. AND GOTTO, A.M., JR. Effect of alcohol intake on high-density lipoprotein cholesterol levels in runners and inactive men. JAMA 249: 747-750, 1983.
50. HASKELL, W.L., CAMARGO, C., JR., WILLIAMS, P.T., VRANIZAN, K.M., KRAUSS, R.M., LINDGREN, F.T. AND WOOD, P.D. The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions: A controlled study. New Engl. J. Med. 310: 805-810, 1984.
51. HASUMURA, Y., MINATO, Y., NISHIMURA, M., KAKU, Y., TOZUKA, S., KOYAMA, W., TANAKA, Y. AND TAKEUCHI, J. Hepatic fibrosis in alcoholics: Morphologic characteristics, clinical diagnosis and natural course. Pathobiol. Hepatic Fibrosis 7: 13-24, 1985.
52. 2-receptor antagonists, and its effect on the bioavailability of ethanol. Alcsm. Clin. Exp. Res. 14: 946-950, 1990.
53. HETU, C., DUMONT, A. AND JOLY, J.-G. Effect of chronic ethanol administration on bromobenzene liver toxicity in the rat. Toxicol. Appl. Pharmacol. 67: 166-177, 1983.
54. HETU, C. AND JOLY, J.-G. Differences in the duration of the enhancement of liver mixed-function oxidase activities in ethanol-fed rats after withdrawal. Biochem. Pharmacol. 34: 1211-1216, 1985.
55. HIGGINS, E.M. AND DU VIVIER, A.W.P. Alcohol and the skin. Alcohol Alcsm. 27: 595-602, 1992.
56. HIGUCHI, S., MURAMATSU, T., MURAYAMA, M. AND HAYASHIDA, M. Association of structural polymorphism of the dopamine D2 receptor gene and alcoholism. Biochem. Biophys. Res. Commun. 204: 1199-1205, 1994.
57. HIRANO, T., KAPLOWITZ, N., TSUKAMOTO, H., KAMIMURA, S. AND FERNANDEZ-CHECA, J.C. Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats. Hepatology 16: 1423-1427, 1992.
58. HOERNER, M., BEHRENS, U.J., WORNER, T.M., BLACKSBERG, I., BRALY, L.F., SCHAFFNER, F. AND LIEBER, C.S. The role of alcoholism and liver disease in the appearance of serum antibodies against acetaldehyde adducts. Hepatology 8: 569-574, 1988.
59. HOERNER, M., BEHRENS, U.J., WORNER, T. AND LIEBER, C.S. Humoral immune response to acetaldehyde adducts in alcoholic patients. Res. Commun. Chem. Pathol. Pharmacol. 54: 3-12, 1986.
60. HOFFMAN, P.L. AND TABAKOFF, B. Alcohol dependence: A commentary on mechanisms. Alcohol Alcsm. 31: 333-340, 1996.
61. HRUBEC, Z. AND OMENN, G.S. Evidence of genetic predisposition to alcoholic cirrhosis and psychosis: Twin concordances for alcoholism and its biological end points by zygosity among male veterans. Alcsm. Clin. Exp. Res. 5: 207-215, 1981.
62. HULTBERG, B., BERGLUND, M., ANDERSSON, A. AND FRANK, A. Elevated plasma homocysteine in alcoholics. Alcsm. Clin. Exp. Res. 17: 687-689, 1993.
63. ISRAEL, Y., HURWITZ, E., NIEMELA, O. AND ARNON, R. Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts. Proc. Nat. Acad. Sci. U.S.A. 83: 7923-7927, 1986.
64. ISRAEL, Y., SPEISKY, H., LANCA, A.J., IWAMURA, S., HIRAI, M. AND VARGHESE, G. Metabolism of hepatic glutathione and its relevance in alcohol induced liver damage. Cell. Molec. Aspects Cirrhosis 216: 25-37, 1992.
65. KAIKAUS, R.M., CHAN, W.K., LYSENKO, N., RAY, R., ORTIZ DE MONTELLANO, P.R. AND BASS, N.M. Induction of peroxisomal fatty acid β-oxidation and liver fatty acid-binding protein by peroxisome proliferators. J. Biol. Chem. 268: 9593-9603, 1993.
66. KALANT, H., KHANNA, J.M. AND MARSHMAN, J. Effect of chronic intake of ethanol on pentobarbital metabolism. J. Pharmacol. 175: 318-324, 1970.
67. KARL, P.I., GORDON, B.H., LIEBER, C.S. AND FISHER, S.E. Acetaldehyde production and transfer by the perfused human placental cotyledon. Science 242: 273-275, 1988.
68. KATER, R.M.H., ROGGIN, G., TOBON, F., ZIEVE, P. AND IBER, F.L. Increased rate of clearance of drugs from the circulation of alcoholics. Amer. J. Med. Sci. 258: 35-39, 1969a.
69. KATER, R.M.H., TOBON, F. AND IBER, F.L. Increased rate of tolbutamide metabolism in alcoholic patients. JAMA 207: 363-365, 1969b.
70. KATO, R. AND YAMAZOE, Y. Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity. Toxicol. Lett. 64/65: 661-667, 1992.
71. KATZ, D., PITCHUMONI, C.S., THOMAS, E. AND ANTONELLE, M. The endoscopic diagnosis of upper gastrointestinal hemorrhage: Changing concepts of etiology and management. Dig. Dis. 21: 182-189, 1976.
72. KENDLER, K.S., HEATH, A.C., NEALE, M.C., KESSLER, R.C. AND EAVES, L.J. A population-based twin study of alcoholism in women. JAMA 268: 1877-1882, 1992.
73. KERSHENOBICH, D., VARGAS, F., GARCIA-TSAO, G., PEREZ-TOMAYO, R., GENT, M. AND ROJKIND, M. Colchicine in the treatment of cirrhosis. New Engl. J. Med. 318: 1709-1713, 1988.
74. KHARASCH, E.D. AND THUMMEL, K.E. Identification of cytochrome P4502E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiology 79: 795-807, 1993.
75. KUMAR, S., STAUBER, R.E., GAVALER, J.S., BASISTA, M.H., DINDZANS, V.J., SCHADE, R.R., RABINOVITZ, M., TARTER, R.E., GORDON, R., STARZL, T.E. AND VAN THIEL, D.H. Orthotopic liver transplantation for alcoholic liver disease. Hepatology 11: 159-164, 1990.
76. LANE, B.P. AND LIEBER, C.S. Ultrastructural alterations in human hepatocytes following ingestion of ethanol with adequate diets. Amer. J. Path. 49: 593-603, 1966.
77. LAPOSATA, E.A. AND LANGE, L.G. Presence of nonoxidative ethanol metabolism in human organs commonly damaged by ethanol abuse. Science 231: 497-499, 1986.
78. LEO, M.A., ARAI, M., SATO, M. AND LIEBER, C.S. Hepatotoxicity of vitamin A and ethanol in the rat. Gastroenterology 82: 194-205, 1982.
79. LEO, M.A., KIM, C.-I. AND LIEBER, C.S. NAD dependent retinol dehydrogenase in liver microsomes. Arch. Biochem. Biophys. 259: 241-249, 1987.
80. LEO, M.A., KIM, C.-I., LOWE, N. AND LIEBER, C.S. Interaction of ethanol with β-carotene: Delayed blood clearance and enhanced hepatotoxicity. Hepatology 15: 883-891, 1992.
81. LEO, M.A. AND LIEBER, C.S. Hepatic vitamin A depletion in alcoholic liver injury. New Engl. J. Med. 307: 597-601, 1982.
82. LEO, M.A. AND LIEBER, C.S. Hepatic fibrosis after long-term administration of ethanol and moderate vitamin A supplementation in the rat. Hepatology 3: 1-11, 1983.
83. LEO, M.A. AND LIEBER, C.S. New pathway for retinol metabolism in liver microsomes. J. Biochem. 260: 5228-5231, 1985.
84. LEO, M.A. AND LIEBER, C.S. Hypervitaminosis A: A liver lover's lament. Hepatology 8: 412-417, 1988.
85. LEO, M.A. AND LIEBER, C.S. Beta carotene, vitamin E and lung cancer (letter). New Engl. J. Med. 331: 612-613, 1994.
86. LEO, M.A., ROSMAN, A.S. AND LIEBER, C.S. Differential depletion of carotenoids and tocopherol in liver disease. Hepatology 17: 977-986, 1993.
87. LI, J.-J., KIM, C.-I., LEO, M.A., MAK, K.M., ROJKIND, M. AND LIEBER, C.S. Polyunsaturated lecithin prevents acetaldehyde-mediated hepatic collagen accumulation by stimulating collagenase activity in cultured lipocytes. Hepatology 15: 373-381, 1992.
88. LI, J.-J., ROSMAN, A.S., LEO, M.A., NAGAI, Y. AND LIEBER, C.S. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis. Hepatology 19: 1418-1423, 1994.
89. LIEBER, C.S. Perspectives: Do alcohol calories count? Amer. J. Clin. Nutr. 54: 976-982, 1991.
90. LIEBER, C.S. (Ed.) Medical and Nutritional Complications of Alcoholism: Mechanisms and Management. New York: Plenum Press, 1992.
91. LIEBER, C.S. Women and alcohol: Gender differences in metabolism and susceptibility. In: GOMBERG, E.S.L. AND NIRENBERG, T.D. (Eds.) Women and Substance Abuse, Norwood, N.J.: Ablex Publishing Corp., 1993, pp. 1-17.
92. LIEBER, C.S. Alcohol and the liver: 1994 update. Gastroenterology 106: 1085-1105, 1994.
93. LIEBER, C.S. Medical disorders of alcoholism. New Engl. J. Med. 333: 1058-1065, 1995.
94. LIEBER, C.S. Pathogenesis and treatment of liver fibrosis: 1996 update. Dig. Dis. 15: 42-66, 1997a.
95. LIEBER, C.S. Gastritis and Helicobacter pylori: Forty years of antibiotic therapy. Digestion 58: 203-210, 1997b.
96. LIEBER, C.S., BARAONA, E., HERNANDEZ-MUNOZ, R., KUBOTA, S., SATO, N., KAWANO, S., MATSUMURA, T. AND INATOMI, N. Impaired oxygen utilization: A new mechanism for the hepatotoxicity of ethanol in subhuman primates. J. Clin. Invest. 83: 1682-1690, 1989.
97. LIEBER, C.S., CASINI, A., DECARLI, L.M., KIM, C.-I., LOWE, N., SASAKI, R. AND LEO, M.A. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon. Hepatology 11: 165-172, 1990a.
98. LIEBER, C.S. AND DAVIDSON, C.S. Complications resulting from renal failure in patients with liver disease. Arch. Intern. Med. 106: 749-752, 1960.
99. LIEBER, C.S. AND DECARLI, L.M. Ethanol oxidation by hepatic microsomes: Adaptive increase after ethanol feeding. Science 162: 917-918, 1968.
100. LIEBER, C.S. AND DECARLI, L.M. Hepatic microsomal ethanol-oxidizing system: In vitro characteristics and adaptive properties in vivo. J. Biol. Chem. 245: 2505-2512, 1970.
101. LIEBER, C.S. AND DECARLI, L.M. An experimental model of alcohol feeding and liver injury in the baboon. J. Med. Primatol. 3: 153-163, 1974.
102. LIEBER, C.S. AND DECARLI, L.M. Hepatotoxicity of ethanol. J. Hepatol. 12: 394-401, 1991.
103. LIEBER, C.S., DECARLI, L.M., MAK, K.M., KIM, C.-I. AND LEO, M.A. Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin. Hepatology 12: 1390-1398, 1990b.
104. LIEBER, C.S., GARRO, A., LEO, M.A., MAK, K.M. AND WORNER, T. Alcohol and cancer. Hepatology 6: 1005-1019, 1986.
105. LIEBER, C.S., JONES, D.P. AND DECARLI, L.M. Effects of prolonged ethanol intake: Production of fatty liver despite adequate diets. J. Clin. Invest. 44: 1009-1021, 1965.
106. LIEBER, C.S. AND LEFÈVRE, A. Effect of oxytetracycline on acidity, ammonia and urea in gastric juice in normal and uremic subjects. CR Soc. Biol. (Paris) 151: 1038-1042, 1957.
107. LIEBER, C.S. AND LEFÈVRE, A. Ammonia and intermediary metabolism in hepatic coma: Value of the determination of blood ammonia in the diagnosis and management of cirrhosis. Acta Clin. Belg. 13: 328-357, 1958.
108. LIEBER, C.S. AND LEFÈVRE, A. Ammonia as source of gastric hypoacidity in patients with uremia. J. Clin. Invest. 38: 1271-1277, 1959.
109. LIEBER, C.S., ROBINS, S.J. AND LEO, M.A. Hepatic phosphatidylethanolamine methyltransferase activity is decreased by ethanol and increased by phosphatidylcholine. Alcsm Clin. Exp. Res. 18: 592-595, 1994a.
110. LIEBER, C.S., ROBINS, S.J., LI, J., DECARLI, L.M., MAK, K.M., FASULO, J.M. AND LEO, M.A. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 106: 152-159, 1994b.
111. LIEBER, C.S. AND SCHMID, R. The effect of ethanol on fatty acid metabolism: Stimulation of hepatic fatty acid synthesis in vitro. J. Clin. Invest. 40: 394-399, 1961.
112. LINNOILA, M., ERWIN, C.W., RAMM, D. AND CLEVELAND, W.P. Effects of age and alcohol on psychomotor performance of men. J. Stud. Alcohol 41: 488-495, 1980.
113. LONGNECKER, M.P., BERLIN, J.A., ORZA, M.J. AND CHALMERS, T.C. A meta-analysis of alcohol consumption in relation to risk of breast cancer. JAMA 260: 652-656, 1988.
114. LOWENFELS, A.B. AND ZEVOLA, S.A. Alcohol and breast cancer: An overview. Alcsm. Clin. Exp. Res. 13: 109-111, 1989.
115. LUMENG, L. AND CRABB, D.W. Genetic aspects and risk factors in alcoholism and alcoholic liver disease. Gastroenterology 107: 572-578, 1994.
116. MCCLAIN, C., HILL, D., SCHMIDT, J. AND DIEHL, A.M. Cytokines and alcoholic liver disease. In: LIEBER, C.S. (Ed.) Alcoholic Liver Disease (Seminars in Liver Disease, Vol. 13, No. 2), New York: Thieme Med. Pubs., 1993, pp. 170-182.
117. MCGINNIS, J.M. AND FOEGE, W.H. Actual causes of death in the United States. JAMA 270: 2207-2212, 1993.
118. MA, X.L., BARAONA, E. AND LIEBER, C.S. Alcohol consumption enhances fatty acid ω-oxidation, with a greater increase in male than in female rats. Hepatology 18: 1247-1253, 1993.
119. MAK, K.M. AND LIEBER, C.S. Lipocytes and transitional cells in alcoholic liver disease: A morphometric study. Hepatology 8: 1027-1033, 1988.
120. MALY, I.P. AND SASSE, D. Intraacinar profiles of alcohol dehydrogenase and aldehyde dehydrogenase activities in human liver. Gastroenterology 101: 1716-1723, 1991.
121. MANN, K., BATRA, A., GUNTHNER, A. AND SCHROTH, G. Do women develop alcoholic brain damage more readily than men? Alcsm Clin. Exp. Res. 16: 1052-1056, 1992.
122. MARIK, P. AND MOHEDIN, B. Alcohol-related admissions to an inner city hospital intensive care unit. Alcohol Alcsm 31: 393-396, 1996.
123. MENDENHALL, C.L., ANDERSON, S., GARCIA-PONT, P., GOLDBERG, S., KIERNAN, T., SEEFF, L.B., SORRELL, M., TAMBURRO, C., WEESNER, R., ZETTERMAN, R., CHEDID, A., CHEN, T. AND RABIN, L. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. New Engl. J. Med. 311: 1464-1470, 1984.
124. MEYERS, S. AND LIEBER C.S. Reduction of gastric ammonia by ampicillin in normal and azotemic subjects. Gastroenterology 70: 244-247, 1976.
125. MIRMIRAN-YAZDY, S.A., HABER, P.S., KORSTEN, M.A., MAK, K.M., GENTRY, R.T., BATRA, S.C. AND LIEBER, C.S. Metabolism of ethanol in rat gastric cells and its inhibition by cimetidine. Gastroenterology 108: 737-742, 1995.
126. MISRA, P.S., LEFÈVRE, A., ISHII, H., RUBIN, E. AND LIEBER, C.S. Increase of ethanol, meprobamate and pentobarbital metabolism after chronic ethanol administration in man and in rats. Amer. J. Med. 51: 346-351, 1971.
127. MORENO, A. AND PARÉS, X. Purification and characterization of a new alcohol dehydrogenase from human stomach. J. Biol. Chem. 266: 1128-1133, 1991.
128. MORGAN, M.Y. AND SHERLOCK, S. Sex-related differences among 100 patients with alcoholic liver disease. Brit. Med. J. 1: 939-941, 1977.
129. MOSHAGE, H., CASINI, A. AND LIEBER, C.S. Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes. Hepatology 12: 511-518, 1990.
130. NIEMELA, O., KLAJNER, F., ORREGO, H., VIDINS, E., BLENDIS, L. AND ISRAEL, Y. Antibodies against acetaldehyde-modified protein epitopes in human alcoholics. Hepatology 7: 1210-1214, 1987.
131. NILSSON, B.E. Conditions contributing to fracture of the femoral neck. Acta Chir. Scand. 136: 383-384, 1970.
132. O'MALLEY, S.S., JAFFE, A.J., CHANG, G., RODE, S., SCHOTTENFELD, R., MEYER, R.E. AND ROUNSAVILLE, B. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch. Gen. Psychiat. 53: 217-224, 1996.
133. OMENN, G.S., GOODMAN, G.E., THORNQUIST, M.D., BALMES, J., CULLEN, M.R., GLASS, A., KEOGH, J.P., MEYSKENS, F.L., VALANIS, B., WILLIAMS, J.H., BARNHART, S. AND HAMMAR, S. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. New Engl. J. Med. 334: 1150-1155, 1996.
134. ORREGO, H., BLAKE, J.E., BLENDIS, L.M., COMPTON, K.V. AND ISRAEL, Y. Long-term treatment of alcoholic liver disease with propylthiouracil. New Engl. J. Med. 317: 1421-1427, 1987.
135. ORREGO, H., KALANT, H., ISRAEL, Y., BLAKE, J., MEDLINE, A., RANKIN, J.G., ARMSTRONG, A. AND KAPUR, B. Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease. Gastroenterology 76: 105-115, 1979.
136. PALMER, R.H., FRANK, W.O., NAMBI, P., WETHERINGTON, J.D. AND FOX, M.J. Effects of various concomitant medications on gastric alcohol dehydrogenase and the first-pass metabolism of ethanol. Amer. J. Gastroenterol. 86: 1749-1755, 1991.
137. PARÉS, X., CEDERLUND, E., MORENO, A., SAUBI, N., HÖÖG, J.-O. AND JÖRNVALL, H. Class IV alcohol dehydrogenase (the gastric enzyme): Structural analysis of human σ-ADH reveals class IV to be variable and confirms the presence of a fifth mammalian alcohol dehydrogenase class. F.E.B.S. Letter 303: 69-72, 1992.
138. PARONETTO, F. Immunologic reactions in alcoholic liver disease. In: LIEBER, C.S. (Ed.) Alcoholic Liver Disease (Seminars in Liver Disease, Vol. 13, No. 2), New York: Thieme Med. Pubs., 1993, pp. 183-195.
139. PARRISH, K.M., DUFOUR, M.C., STINSON, F.S. AND HARFORD, T.C. Average daily alcohol consumption during adult life among decedents with and without cirrhosis: The 1986 National Mortality Followback Survey. J. Stud. Alcohol 54: 450-456, 1993.
140. PEQUIGNOT, G., TUYNS, A.J. AND BERTA, J.L. Ascitic cirrhosis in relation to alcohol consumption. Int. J. Epidemiol. 7: 113-120, 1978.
141. PERLOW, W., BARAONA, E. AND LIEBER, C.S. Symptomatic intestinal disaccharidase deficiency in alcoholics. Gastroenterology 72: 680-684, 1977.
142. PIGNON, J-P., BAILEY, N.C., BARAONA, E. AND LIEBER, C.S. Fatty acid-binding protein: A major contributor to the ethanol-induced increase in liver cytosolic proteins in the rat. Hepatology 7: 865-871, 1987.
143. POTTER, J.F. AND JAMES, O.F.W. Clinical features and prognosis of alcoholic liver disease in respect of advancing age. Gerontology 33: 380-387, 1987.
144. POUPON, R.E., NAPALAS, B., COUTELLE, C., FLEURY, B., COUZIGOU, P., HIGUERET, D. AND THE FRENCH GROUP FOR RESEARCH ON ALCOHOL AND LIVER. Polymorphism of the alcohol dehydrogenase, alcohol and aldehyde dehydrogenase activities: Implications in alcoholic cirrhosis in white patients. Hepatology 15: 1017-1022, 1992.
145. PRITCHARD, J.F. AND SCHNECK, D.W. Effects of ethanol and phenobarbital on the metabolism of propranolol by 9000 g rat liver supernatant. Biochem. Pharmacol. 26: 2453-2454, 1977.
146. PROJECT MATCH RESEARCH GROUP. Matching alcoholism treatments to client heterogeneity: Project MATCH Posttreatment Drinking Outcomes. J. Stud. Alcohol 58: 7-29, 1997.
147. RABINOVITZ, M., VAN THIEL, D.H., DINDZANS, V. AND GAVALER, J.S. Endoscopic findings in alcoholic liver disease: Does gender make a difference? Alcohol 6: 465-468, 1989.
148. RANKIN, J.G. The natural history and management of the patient with alcoholic liver disease. In: FISHER, M.M. AND RANKIN, J.G. (Eds.) Alcohol and the Liver, New York: Plenum Press, 1977, pp. 365-381.
149. RAUCY, J.L., LASKER, J.M., LIEBER, C.S. AND BLACK, M. Acetaminophen activation by human liver cytochromes P450HE1 and P450IA2. Arch. Biochem. Biophys. 271: 270-283, 1989.
150. RAUFMAN, J.-P., NOTAR-FRANCESCO, V., RAFFANIELLO, R.D. AND STRAUS, E.W. Histamine-2 receptor antagonists do not alter serum ethanol levels in fed, nonalcoholic men. Ann. Intern. Med. 118: 488-494, 1993.
151. RENAUD, S. AND DELORGERIL, M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339: 1523-1526, 1992.
152. RIDKER, P.M., VAUGHN, D.E., STAMPER, M.J., GLYNN, R.J. AND HENNEKENS, C.H. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 272: 929-933, 1994.
153. ROINE, R., GENTRY, R.T., HERNANDEZ-MUNOZ, R., BARAONA, E. AND LIEBER, C.S. Aspirin increases blood alcohol concentrations in humans after ingestion of ethanol. JAMA 264: 2406-2408, 1990.
154. ROINE, R.P., GENTRY, R.T., LIM, R.T., JR., BARAONA, E. AND LIEBER, C.S. Effect of concentration of ingested ethanol on blood alcohol levels. Alcsm Clin. Exp. Res. 15: 734-738, 1991.
155. ROSMAN, A.S., PARONETTO, F., GALVIN, K., WILLIAMS, R.J. AND LIEBER, C.S. Hepatitis C virus antibody in alcoholic patients: Association with the presence of portal and/or lobular hepatitis. Arch. Intern. Med. 153: 965-969, 1993.
156. SALASPURO, M.P. AND LIEBER, C.S. Non-uniformity of blood ethanol elimination: Its exaggeration after chronic consumption. Ann. Clin. Res. 10: 294-297, 1978.
157. SATO, C., MATSUDA, Y. AND LIEBER, C.S. Increased hepatotoxicity of acetaminophen after chronic ethanol consumption in the rat. Gastroenterology 80: 140-148, 1981.
158. SATO, M. AND LIEBER, C.S. Hepatic vitamin A depletion after chronic ethanol consumption in baboons and rats. J. Nutr. 111: 2015-2023, 1981.
159. SATRE, M.A., ZGOMBIC-KNIGHT, M. AND DUESTER, G. The complete structure of human class IV alcohol dehydrogenase (retinol dehydrogenase) determined from the ADH 7 gene. J. Biol. Chem. 269: 15606-15612, 1994.
160. SAVILLE, P.D. Changes in bone mass with age and alcoholism. J. Bone Joint Surg. 47: 429-499, 1965.
161. SAVOLAINEN, V.T., PAJARINEN, J., PEROLA, M., PENTILLÄ, A. AND KARHUNEN, P.J. Glutathione-S-transferase GST M1 "null" genotype and the risk of alcoholic liver disease. Alcsm. Clin. Exp. Res. 20: 1340-1345, 1996.
162. SCHATZKIN, A., JONES, Y., HOOVER, R.N., TAYLOR, P.R., BRINTON, L.A., ZIEGLER, R.G., HARVEY, E.B., CARTER, C.L., LICITRA, L.M., DUFOUR, M.C. AND LARSON, D.B. Alcohol consumption and breast cancer in the Epidemiologic Follow-up Study of the First National Health and Nutrition Examination Survey. New Engl. J. Med. 316: 1169-1173, 1987.
163. SEEFF, L.B., CUCHERINI, B.A., ZIMMERMAN, H.J., ALDER E. AND BENJAMIN, S.B. Acetaminophen hepatotoxicity in alcoholics: A therapeutic misadventure. Ann. Intern. Med. 104: 399-404, 1986.
164. SEITZ, H.K., EGERER, G., SIMANOWSKI, U.A., WALDHERR, R., ECKEY, R., AGARWAL, D.P., GOEDDE, H.W. AND VON WARTBURG, J.-P. Human gastric alcohol dehydrogenase activity: Effect of age, sex, and alcoholism. Gut 34: 1433-1437, 1993.
165. SEITZ, H.K., SIMANOWSKI, U.A., EGERER, G., WALDHERR, R. AND OERTL, U. Human gastric alcohol dehydrogenase: In vitro characteristics and effect of cimetidine. Digestion 51: 80-85, 1992.
166. 2-receptor antagonists and ethanol metabolism in man and in rats. Hepatology 4: 1231-1234, 1984.
167. SELLMAN, R., KANTO, J., RAIJOLA, E. AND PEKKARINEN, A. Human and animal study on elimination from plasma and metabolism of diazepam after chronic alcohol intake. Acta Pharmacol. Toxicol. 36: 33-38, 1975.
168. SHARMA, R., GENTRY, R.T., LIM, R.T., JR. AND LIEBER, C.S. First pass metabolism of alcohol: Absence of diurnal variation and its inhibition by cimetidine after an evening meal. Dig. Dis. Sci. 40: 2091-2097, 1995.
169. SHEVCHUK, O., BARAONA, E., MA, X.-L., PIGNON, J.-P. AND LIEBER, C.S. Gender differences in the response of hepatic fatty acids and cytosolic fatty acid-binding capacity to alcohol consumption in rats. Proc. Soc. Exp. Biol. Med. 198: 584-590, 1991.
170. SIEGERS, C.-P., HEIDBUCHEL, K. AND YOUNES, M. Influence of alcohol, dithiocarb and (+)-catechin on the hepatotoxicity and metabolism of vinylidene chloride in rats. J. Appl. Toxicol. 3: 90-95, 1983.
171. SOLOMON, L. Drug-induced arthropathy and necrosis of the femoral head. J. Bone Joint Surg. (Br) 55: 246-261, 1973.
172. SOTANIEMI, E.A., ANTTILA, M., RAUTIO, A., STENGARD, J., SAUKKO, P. AND JARVENSIVU, P. Propranolol and sotalol metabolism after a drinking party. Clin. Pharmacol. Ther. 29: 705-710, 1981.
173. SPEISKY, H., MACDONALD, A., GILES, G., ORREGO, H. AND ISRAEL, Y. Increased loss and decreased synthesis of hepatic glutathione after acute ethanol administration: Turnover studies. Biochem. J. 225: 565-572, 1985.
174. STAMPFER, M.J., COLDITZ, G.A., WILLETT, W.C., MANSON, J.E., ARKY, R.A., HENNEKENS, C.H. AND SPEIZER, F.E. A prospective study of moderate alcohol drinking and risk of diabetes in women. Amer. J. Epidemiol. 128: 549-558, 1988.
175. STAMPFER, M.J., MALINOW, R., WILLETT, W.C., NEWCOMER, L.M., UPSON, B., ULLMAN, D., TISCHLER, P.V. AND HENNEKENS, C.H. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in U.S. physicians. JAMA 268: 877-881, 1992.
176. TAKAGI, T., ISHII, H., TAKAHASHI, H., KATO, S., OKUNO, F., EBIHARA, Y., YAMAUCHI, H., NAGATA, S., TASHIRO, M., AND TSUCHIYA, M. Potentiation of halothane hepatotoxicity by chronic ethanol administration in rat: An animal model of halothane hepatitis. Pharmacol. Biochem. Behav. 18 (Suppl 1): 461-465, 1983.
177. TAKAHASHI, T., LASKER, J.M., ROSMAN, A.S. AND LIEBER, C.S. Induction of cytochrome P-4502E1 in the human liver by ethanol caused by a corresponding increase in encoding messenger RNA. Hepatology 17: 236-245, 1993.
178. TASKINEN, M.-R., VALIMAKI, M., NIKKILA, E.A., KUUSI, T., EHNHOLM, C. AND YLIKAHRI, R. High density lipoprotein subfractions and postheparin plasma lipases in alcoholic men before and after ethanol withdrawal. Metabolism 31: 1168-1174, 1982.
179. TESCHKE, R. AND WIESE, B. Sex-dependency of hepatic alcohol metabolizing enzymes. J. Endocrinol. Invest. 5: 243-250, 1982.
180. TSUTSUMI, M., LASKER, J.M., SHIMIZU, M., ROSMAN, A.S. AND LIEBER, C.S. The intralobular distribution of ethanol-inducible P450IIE1 in rat and human
181. TSUTSUMI, R., LEO, M.A., KIM, C.-I., TSUTSUMI, M., LASKER, J., LOWE, N. AND LIEBER, C.S. Interaction of ethanol with enflurane metabolism and toxicity: Role of P450IIE1. Alcsm Clin. Exp. Res. 14: 174-179, 1990.
182. TSYRLOV, I.E., SALMELA, K.S., KESSOVA, I.G., MISHIN, V.M. AND LIEBER, C.S. Effect of combined ethanol and 3-methylcholanthrene treatment on hepatic microsomal P4502E1 and P4501A2 in rats (Abstract). Alcsm Clin. Exp. Res. 20 (No. 2, Suppl.): 37a, 1996.
183. UPPAL, R., LATEEF, S.K., KORSTEN, M.A., PARONETTO, F. AND LIEBER, C.S. Chronic alcoholic gastritis: Roles of ethanol and Helicobacter pylori. Arch. Intern. Med. 151: 760-764, 1991.
184. VICTOR, M. The effects of alcohol on the nervous system: Clinical features, pathogenesis, and treatment. In: LIEBER, C.S. (Ed.) Medical and Nutritional Complications of Alcoholism: Mechanisms and Management, New York: Plenum Medical Book Co., 1992, pp. 413-457.
185. WALD, A., VAN THIEL, D.H., HOECHSTETTER, L., GAVALER, J.S., EGLER, K.M., VERM, R., SCOTT, L. AND LESTER, R. Effect of pregnancy on gastrointestinal transit. Dig. Dis. Sci. 27: 1015-1018, 1982.
186. WEINER, F.R., ESKREIS, D.S., COMPTON, K.V., ORREGO, H. AND ZERN, M.A. Haplotype analysis of a type I collagen gene and its association with alcoholic cirrhosis in man. Molec. Aspects Med. 10: 93-194, 1988.
187. WHITECOMB, D.C. AND BLOCK, G.D. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 272: 1845-1850, 1994.
188. WILLETT, W.C., STAMPFER, M.J., COLDITZ, G.A., ROSNER, B.A., HENNEKENS, C.H. AND SPEIZER, F.E. Moderate alcohol consumption and the risk of breast cancer. New Engl. J. Med. 316: 1174-1180, 1987.
189. WONDERGEM, R. AND DAVIS, J. Ethanol increases hepatocyte water volume. Alcsm Clin. Exp. Res. 18: 1230-1236, 1994.
190. WORNER, T.M. AND LIEBER, C.S. Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 254: 627-630, 1985.
191. YAMADA, S., MAK, K.M. AND LIEBER, C.S. Chronic ethanol consumption alters rat liver plasma membranes and potentiates release of alkaline phosphatase. Gastroenterology 88: 1799-1806, 1985.
192. YOKOYAMA, H., BARAONA, E. AND LIEBER, C.S. Molecular cloning of human class IV alcohol dehydrogenase cDNA. Biochem. Biophys. Res. Commun. 203: 219-224, 1994.
193. YOKOYAMA, H., BARAONA, E. AND LIEBER, C.S. Molecular cloning and chromosomal localization of ADH7 gene encoding human class IV σ ADH. Genomics 31: 243-245, 1996.
194. ZORZANO, A. AND HERRARA, E. In vivo ethanol elimination in man, monkey and rat: A lack of relationship between the ethanol metabolism and the hepatic activities of alcohol and aldehyde dehydrogenases. Life Sci. 46: 223-230, 1990.
195. ZUREIK, M. AND DUCIMETIÈRE, P. High alcohol-related premature mortality in France: Concordant estimates from a prospective cohort study and national mortality statistics. Alcsm Clin. Exp. Res. 20: 428-433, 1996.